vs

Side-by-side financial comparison of BJs RESTAURANTS INC (BJRI) and CLOVER HEALTH INVESTMENTS, CORP. (CLOV). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $355.4M, roughly 1.4× BJs RESTAURANTS INC). BJs RESTAURANTS INC runs the higher net margin — 3.6% vs -10.1%, a 13.7% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs -73.8%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 2.6%).

BJ's Restaurants Inc. operates a chain of casual dining restaurants across the United States. Its menu features signature deep-dish pizzas, craft beers, handcrafted cocktails, and a wide range of American comfort food. The brand primarily serves family groups, friend gatherings, and casual diners seeking affordable, high-quality meals in a relaxed, welcoming in-store environment.

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

BJRI vs CLOV — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.4× larger
CLOV
$487.7M
$355.4M
BJRI
Growing faster (revenue YoY)
CLOV
CLOV
+118.6% gap
CLOV
44.7%
-73.8%
BJRI
Higher net margin
BJRI
BJRI
13.7% more per $
BJRI
3.6%
-10.1%
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
2.6%
BJRI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BJRI
BJRI
CLOV
CLOV
Revenue
$355.4M
$487.7M
Net Profit
$12.6M
$-49.3M
Gross Margin
74.5%
Operating Margin
-10.1%
Net Margin
3.6%
-10.1%
Revenue YoY
-73.8%
44.7%
Net Profit YoY
-24.2%
-123.2%
EPS (diluted)
$0.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BJRI
BJRI
CLOV
CLOV
Q4 25
$355.4M
$487.7M
Q3 25
$365.6M
$496.6M
Q2 25
$348.0M
$477.6M
Q1 25
$462.3M
Q4 24
$325.7M
$337.0M
Q3 24
$349.9M
$331.0M
Q2 24
$337.3M
$356.3M
Q1 24
$346.9M
Net Profit
BJRI
BJRI
CLOV
CLOV
Q4 25
$12.6M
$-49.3M
Q3 25
$22.2M
$-24.4M
Q2 25
$13.5M
$-10.6M
Q1 25
$-1.3M
Q4 24
$-2.9M
$-22.1M
Q3 24
$17.2M
$-9.2M
Q2 24
$7.7M
$7.4M
Q1 24
$-19.2M
Gross Margin
BJRI
BJRI
CLOV
CLOV
Q4 25
74.5%
Q3 25
75.2%
Q2 25
75.0%
Q1 25
Q4 24
73.4%
Q3 24
74.3%
24.5%
Q2 24
74.8%
30.3%
Q1 24
23.6%
Operating Margin
BJRI
BJRI
CLOV
CLOV
Q4 25
-10.1%
Q3 25
5.8%
-4.9%
Q2 25
4.3%
-2.2%
Q1 25
-0.3%
Q4 24
-0.8%
-6.4%
Q3 24
3.8%
-2.7%
Q2 24
2.4%
2.0%
Q1 24
-6.5%
Net Margin
BJRI
BJRI
CLOV
CLOV
Q4 25
3.6%
-10.1%
Q3 25
6.1%
-4.9%
Q2 25
3.9%
-2.2%
Q1 25
-0.3%
Q4 24
-0.9%
-6.6%
Q3 24
4.9%
-2.8%
Q2 24
2.3%
2.1%
Q1 24
-5.5%
EPS (diluted)
BJRI
BJRI
CLOV
CLOV
Q4 25
$0.58
Q3 25
$0.97
Q2 25
$0.58
Q1 25
Q4 24
$-0.13
Q3 24
$0.72
Q2 24
$0.32
Q1 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BJRI
BJRI
CLOV
CLOV
Cash + ST InvestmentsLiquidity on hand
$23.8M
$78.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$366.2M
$308.7M
Total Assets
$1.0B
$541.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BJRI
BJRI
CLOV
CLOV
Q4 25
$23.8M
$78.3M
Q3 25
$26.0M
Q2 25
$19.0M
Q1 25
Q4 24
$18.4M
$194.5M
Q3 24
$16.2M
$288.0M
Q2 24
$18.8M
$254.8M
Q1 24
$208.3M
Total Debt
BJRI
BJRI
CLOV
CLOV
Q4 25
Q3 25
$60.5M
Q2 25
$85.5M
Q1 25
Q4 24
$66.5M
Q3 24
$63.5M
Q2 24
$58.0M
Q1 24
Stockholders' Equity
BJRI
BJRI
CLOV
CLOV
Q4 25
$366.2M
$308.7M
Q3 25
$386.6M
$340.9M
Q2 25
$371.5M
$344.2M
Q1 25
$336.1M
Q4 24
$376.2M
$341.1M
Q3 24
$386.5M
$342.2M
Q2 24
$375.4M
$324.9M
Q1 24
$292.5M
Total Assets
BJRI
BJRI
CLOV
CLOV
Q4 25
$1.0B
$541.0M
Q3 25
$1.0B
$559.7M
Q2 25
$1.0B
$575.0M
Q1 25
$583.7M
Q4 24
$1.0B
$580.7M
Q3 24
$1.0B
$653.0M
Q2 24
$1.0B
$674.2M
Q1 24
$671.8M
Debt / Equity
BJRI
BJRI
CLOV
CLOV
Q4 25
Q3 25
0.16×
Q2 25
0.23×
Q1 25
Q4 24
0.18×
Q3 24
0.16×
Q2 24
0.15×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BJRI
BJRI
CLOV
CLOV
Operating Cash FlowLast quarter
$-66.9M
Free Cash FlowOCF − Capex
$-69.0M
FCF MarginFCF / Revenue
-14.1%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BJRI
BJRI
CLOV
CLOV
Q4 25
$-66.9M
Q3 25
$62.3M
$12.1M
Q2 25
$4.6M
$5.4M
Q1 25
$-16.3M
Q4 24
$27.3M
$34.8M
Q3 24
$20.2M
$50.0M
Q2 24
$22.3M
$44.8M
Q1 24
$25.9M
Free Cash Flow
BJRI
BJRI
CLOV
CLOV
Q4 25
$-69.0M
Q3 25
$41.9M
$11.4M
Q2 25
$-12.1M
$4.8M
Q1 25
$-16.5M
Q4 24
$7.6M
$33.3M
Q3 24
$735.0K
$49.6M
Q2 24
$448.0K
$44.4M
Q1 24
$25.5M
FCF Margin
BJRI
BJRI
CLOV
CLOV
Q4 25
-14.1%
Q3 25
11.5%
2.3%
Q2 25
-3.5%
1.0%
Q1 25
-3.6%
Q4 24
2.3%
9.9%
Q3 24
0.2%
15.0%
Q2 24
0.1%
12.5%
Q1 24
7.3%
Capex Intensity
BJRI
BJRI
CLOV
CLOV
Q4 25
0.4%
Q3 25
5.6%
0.1%
Q2 25
4.8%
0.1%
Q1 25
0.0%
Q4 24
6.0%
0.5%
Q3 24
5.6%
0.1%
Q2 24
6.5%
0.1%
Q1 24
0.1%
Cash Conversion
BJRI
BJRI
CLOV
CLOV
Q4 25
Q3 25
2.80×
Q2 25
0.34×
Q1 25
Q4 24
Q3 24
1.18×
Q2 24
2.89×
6.04×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons